RemeGen (9995.HK) Earnings Analysis

RemeGen (9995.HK) has no confirmed upcoming earnings date. Trailing P/E 54.64.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 9995.HK next report earnings?

No confirmed upcoming earnings date is currently scheduled for 9995.HK. This page updates as the calendar is published.

9995.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-252.51 HKDn/an/an/a
2025-10-30-0.19679 HKDn/an/an/a
2025-08-22-0.40281 HKDn/an/an/a
2025-04-24-0.49087 HKDn/an/an/a
2025-02-27-0.78746 HKDn/an/an/a
2024-08-16-0.85869 HKDn/an/an/a

9995.HK valuation and analyst view

Trailing P/E54.64
Trailing EPS2.307 HKD
Price / book17.74
Dividend yield0.00%
Market cap47.48B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is RemeGen (9995.HK)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 9995.HK. This page updates as the calendar is published.

Did 9995.HK beat earnings last quarter?

Consensus estimate data was not available for 9995.HK's 2026-03-25 report.

What is 9995.HK's current P/E ratio and EPS?

9995.HK trades at a trailing P/E of 54.64 on trailing EPS of 2.30726018443346 HKD.

What do analysts rate 9995.HK?

9995.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.